Summary

Description

The Precision Medicine Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The Increasing Adoption of Targeted Therapies is Driving Market Growth

The growing focus on treatments customised to each patient’s unique characteristics is driving substantial growth in the precision medicine market, supported by the demand for more effective, personalised therapies with fewer adverse effects. With increasing cases of cancer, rare genetic disorders, and chronic diseases, biomarker-based therapies and companion diagnostics are proving highly impactful. This has led to greater investment from pharma companies and research institutions in developing treatments tailored to individual genetic profiles.

For instance, on December 20, 2024, Pfizer’s BRAFTOVI, a combination treatment targeting metastatic colorectal cancer with the BRAF V600E mutation, received approval from the U.S. Food and Drug Administration (FDA). Similarly, on November 27, 2024, the European Commission granted approval for Novartis’ Kisqali to treat a broader population of patients with hormone receptor-positive (HR+), HER2-negative early-stage breast cancer who face a high risk of recurrence. These approvals highlight the rising focus on genetically guided treatments, set to transform the precision medicine landscape by enhancing survival rates and patient outcomes. With ongoing advances in genomic sequencing, AI-driven analytics, and liquid biopsy technologies, the demand for targeted therapies is expected to grow rapidly, solidifying precision medicine as a key pillar of future healthcare.

Lack of Interoperability Across Healthcare Data Systems Is Likely to Hinder Market Growth

One of the key barriers to realizing the full potential of precision medicine is the lack of interoperability across healthcare data systems. Precision medicine depends on the seamless integration of genomic data, electronic health records (EHRs), real-world evidence, and biomarker insights but fragmented data sources hinder this process. Without standardized frameworks for data sharing, clinicians, researchers, and pharma companies face difficulties in accessing and utilizing patient-specific information effectively.

For instance, genomic data from sequencing platforms often don’t align with hospital EHR systems, limiting physicians’ ability to make informed treatment decisions. Patients receiving care from multiple providers may also experience fragmented records, reducing the effectiveness of personalized therapies. This data disconnect extends to pharmaceutical R&D, where incomplete datasets slow down biomarker discovery and clinical trials. Overcoming these challenges calls for standardized data exchange protocols, AI-powered integration tools, and stronger collaboration among healthcare providers, tech developers, and regulators to drive progress in precision medicine.

What would be the Impact of the U.S. Trade Tariffs on the Global Precision Medicine Market?

The impact of the U.S. trade tariffs extends beyond production to the accessibility and affordability of precision medicine solutions for patients. As manufacturers pass increased costs down the supply chain, hospitals and clinics may be forced to charge more for advanced genomic tests, targeted therapies, and personalised diagnostics services that are already relatively expensive. This price inflation risks widening the healthcare gap, making precision medicine even less accessible in underfunded or rural healthcare systems, both in the U.S. and abroad. In countries that rely heavily on the U.S.-based technologies or partnerships, these disruptions could delay the adoption of new medical innovations, particularly those tailored to specific genetic or regional population needs.

The precision medicine market thrives on global collaboration among researchers, data scientists, and clinicians across borders, who often share genomic datasets, clinical trial resources, and AI-based diagnostic tools. Trade tensions and tariffs can create a ripple effect, weakening international research alliances and data-sharing efforts due to increased compliance barriers, licensing issues, or protectionist policies.

What Questions Should You Ask before Buying a Market Research Report?

• How is the precision medicine market evolving?
• What is driving and restraining the precision medicine market?
• How will each precision medicine submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
• How will the market shares for each precision medicine submarket develop from 2025 to 2035?
• What will be the main driver for the overall market from 2025 to 2035?
• Will leading precision medicine markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
• Who are the leading players and what are their prospects over the forecast period?
• What are the precision medicine projects for these leading companies?
• How will the industry evolve during the period between 2025 and 2035? What are the implications of precision medicine projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the precision medicine market?
• Where is the precision medicine market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the precision medicine market today, and over the next 10 years:

• Our 463-page report provides 187 tables, 293 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analysis reveal commercial prospects

• In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
• You will find original analysis, with business outlooks and developments.
• Discover qualitative analysis (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising precision medicine prices and recent developments.

Segments Covered in the Report

Product

• Therapeutics
  – Monoclonal Antibodies
  – Inhibitor Drugs
  – Cell & Gene Therapies
  – RNA-Based Therapies
  – Others
• Diagnostics
  – Genetic Tests
  – Biomarker-based Tests
  – Other Diagnostic Tests

Application

• Oncology
• Immunology
• CNS
• Respiratory
• Others

Technology

• Gene Sequencing
• Drug Discovery
• Big Data Analytics
• Companion Diagnostics
• Bioinformatics
• Other Technologies

End-users

• Hospitals
• Diagnostic Centers
• Research & Academic Institutes
• Other End-users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Denmark
• Rest of Europe

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• Singapore
• Thailand
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Precision Medicine Market, 2025 to 2035, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

• 23andMe, Inc.
• Abbott
• Abnova Corporation
• Adaptive Biotechnologies
• Agilent Technologies Inc.
• AstraZeneca
• Bayer AG
• Biogen
• bioMerieux SA
• Bristol-Myers Squibb Company
• Bruker Corporation
• Danaher
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• GE HealthCare
• GRAIL Inc.
• GSK plc
• Illumina, Inc.
• Johnson & Johnson
• Laboratory Corporation of America Holdings
• Myriad Genetics Inc
• Novartis AG
• Pfizer Inc.
• Qiagen
• Quest Diagnostics Incorporated
• Regeneron Pharmaceuticals
• Tempus
• Teva Pharmaceutical Industries Ltd.

Overall world revenue for Precision Medicine Market, 2025 to 2035 in terms of value the market will surpass US$150 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Precision Medicine Market, 2025 to 2035 report help you?

In summary, our 460+ page report provides you with the following knowledge:

• Revenue forecasts to 2035 for Precision Medicine Market, 2025 to 2035, with forecasts for product, application, technology, and end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2035 for five regional and 25 key national markets – See forecasts for the Precision Medicine Market, 2025 to 2035 in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 28 of the major companies involved in the Precision Medicine Market, 2025 to 2035.

Find quantitative and qualitative analysis with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Precision Medicine Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Increasing Global Burden of Cancer Boosts the Demand for Personalized Medicine
3.3.1.2 Increase in Scope of Application of Precision Medicine
3.3.1.3 Accelerating Demand for Targeted Therapy
3.3.1.4 Growing Precedence of Precision Medicine Over Traditional Practice of “One-Size-Fits-All” Therapies
3.3.2 Market Restraining Factors
3.3.2.1 High Cost of Precision Medicine
3.3.2.2 Lack of Data Interoperability
3.3.2.3 Insufficient Funding for Diagnostics Space in the Emerging Economies
3.3.3 Market Opportunities
3.3.3.1 Growing Use of AI in Healthcare is Boosting Demand for Precision Medicine
3.3.3.2 Growing Acceptance of Gene Therapy and Gene Editing Technology
3.4 U.S. Tariffs: What’s the Impact on Global Precision Medicine Market?
3.4.1 Overview
3.4.2 V-Shaped Recovery Scenario
3.4.2.1 Why V-Shaped Recovery?
3.4.2.2 Impact from Tariffs
3.4.2.3 Market Dynamics and Demand Recovery
3.4.2.4 Policy and Funding Support
3.4.2.5 Timeframe for Recovery
3.4.3 U-Shaped Recovery Scenario
3.4.3.1 Why U-Shaped Recovery?
3.4.3.2 Impact from Tariffs
3.4.3.3 Market Dynamics and Demand Recovery
3.4.3.4 Policy and Funding Support
3.4.3.5 Timeframe for Recovery
3.4.4 L Shaped Recovery Scenario
3.4.4.1 Why L-Shaped Recovery?
3.4.4.2 Impact from Tariffs
3.4.4.3 Market Dynamics and Demand Recovery
3.4.4.4 Policy and Funding Support
3.4.4.5 Timeframe for Recovery
3.4.5 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
3.4.6 Impact of U.S. and China Trade War on Precision Medicine Market
3.4.7 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.4.8 Global Market Tariff Sensitivity and Margin Pressure Analysis
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power of Supplier
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 SWOT Analysis
3.7 PEST Analysis

4 Precision Medicine Market Analysis by Product Type
4.1 Key Findings
4.2 Product Type Segment: Market Attractiveness Index
4.3 Precision Medicine Market Size Estimation and Forecast by Product Type
4.4 Therapeutics
4.4.1 Therapeutics Segment: Market Attractiveness Index
4.4.2 Therapeutics Market Size Estimation and Forecast by Type
4.4.3 Market Size by Region, 2025-2035 (US$ Billion)
4.4.4 Market Share by Region, 2025 & 2035 (%)
4.4.5 Monoclonal Antibodies
4.4.5.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.5.2 Market Share by Region, 2025 & 2035 (%)
4.4.6 Inhibitor Drugs
4.4.6.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.6.2 Market Share by Region, 2025 & 2035 (%)
4.4.7 Cell & Gene Therapies
4.4.7.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.7.2 Market Share by Region, 2025 & 2035 (%)
4.4.8 RNA-Based Therapies
4.4.8.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.8.2 Market Share by Region, 2025 & 2035 (%)
4.4.9 Others
4.4.9.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.9.2 Market Share by Region, 2025 & 2035 (%)
4.5 Diagnostics
4.5.1 Diagnostics Segment: Market Attractiveness Index
4.5.2 Diagnostics Market Size Estimation and Forecast by Type
4.5.3 Market Size by Region, 2025-2035 (US$ Billion)
4.5.4 Market Share by Region, 2025 & 2035 (%)
4.5.5 Genetic Tests
4.5.5.1 Market Size by Region, 2025-2035 (US$ Billion)
4.5.5.2 Market Share by Region, 2025 & 2035 (%)
4.5.6 Biomarker-based Tests
4.5.6.1 Market Size by Region, 2025-2035 (US$ Billion)
4.5.6.2 Market Share by Region, 2025 & 2035 (%)
4.5.7 Others
4.5.7.1 Market Size by Region, 2025-2035 (US$ Billion)
4.5.7.2 Market Share by Region, 2025 & 2035 (%)

5 Precision Medicine Market, by Application, 2025-2035
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Precision Medicine Market Size Estimation and Forecast by Application
5.4 Oncology
5.4.1 Market Size by Region, 2025-2035 (US$ Billion)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Immunology
5.5.1 Market Size by Region, 2025-2035 (US$ Billion)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 CNS
5.6.1 Market Size by Region, 2025-2035 (US$ Billion)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.7 Respiratory
5.7.1 Market Size by Region, 2025-2035 (US$ Billion)
5.7.2 Market Share by Region, 2025 & 2035 (%)
5.8 Others
5.8.1 Market Size by Region, 2025-2035 (US$ Billion)
5.8.2 Market Share by Region, 2025 & 2035 (%)

6 Precision Medicine Market, by Technology, 2025-2035
6.1 Key Findings
6.2 Technology Segment: Market Attractiveness Index
6.3 Precision Medicine Market Size Estimation and Forecast by Technology
6.4 Gene Sequencing
6.4.1 Market Size by Region, 2025-2035 (US$ Billion)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Drug Discovery
6.5.1 Market Size by Region, 2025-2035 (US$ Billion)
6.5.2 Market Share by Region, 2025 & 2035 (%)
6.6 Big Data Analytics
6.6.1 Market Size by Region, 2025-2035 (US$ Billion)
6.6.2 Market Share by Region, 2025 & 2035 (%)
6.7 Companion Diagnostics
6.7.1 Market Size by Region, 2025-2035 (US$ Billion)
6.7.2 Market Share by Region, 2025 & 2035 (%)
6.8 Bioinformatics
6.8.1 Market Size by Region, 2025-2035 (US$ Billion)
6.8.2 Market Share by Region, 2025 & 2035 (%)
6.9 Other Technologies
6.9.1 Market Size by Region, 2025-2035 (US$ Billion)
6.9.2 Market Share by Region, 2025 & 2035 (%)

7 Precision Medicine Market, by End-users, 2025-2035
7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 Precision Medicine Market Size Estimation and Forecast by End-users
7.4 Hospitals
7.4.1 Market Size by Region, 2025-2035 (US$ Billion)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.5 Diagnostic Centres
7.5.1 Market Size by Region, 2025-2035 (US$ Billion)
7.5.2 Market Share by Region, 2025 & 2035 (%)
7.6 Research & Academic Institutes
7.6.1 Market Size by Region, 2025-2035 (US$ Billion)
7.6.2 Market Share by Region, 2025 & 2035 (%)
7.7 Other End-users
7.7.1 Market Size by Region, 2025-2035 (US$ Billion)
7.7.2 Market Share by Region, 2025 & 2035 (%)

8 Precision Medicine Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Precision Medicine Market Analysis
9.1 Key Findings
9.2 North America Precision Medicine Market Attractiveness Index
9.3 North America Precision Medicine Market Size by Country, 2025, 2030 & 2035 (US$ Billion)
9.4 North America Precision Medicine Market Size Estimation and Forecast by Country
9.5 North America Precision Medicine Market Size Estimation and Forecast by Product Type
9.5.1 North America Therapeutics Market Size Estimation and Forecast by Type
9.5.2 North America Diagnostics Market Size Estimation and Forecast by Type
9.6 North America Precision Medicine Market Size Estimation and Forecast by Application
9.7 North America Precision Medicine Market Size Estimation and Forecast by Technology
9.8 North America Precision Medicine Market Size Estimation and Forecast by End-users
9.9 U.S. Precision Medicine Market Analysis
9.10 Canada Precision Medicine Market Analysis

10 Europe Precision Medicine Market, 2025-2035
10.1 Key Findings
10.2 Europe Precision Medicine Market Attractiveness Index
10.3 Europe Precision Medicine Market by Country, 2025, 2030 & 2035 (US$ Billion)
10.4 Europe Precision Medicine Market Size Estimation and Forecast by Country
10.5 Europe Precision Medicine Market Size Estimation and Forecast by Product Type
10.5.1 Europe Therapeutics Market Size Estimation and Forecast by Type
10.5.2 Europe Diagnostics Market Size Estimation and Forecast by Type
10.6 Europe Precision Medicine Market Size Estimation and Forecast by Application
10.7 Europe Precision Medicine Market Size Estimation and Forecast by Technology
10.8 Europe Precision Medicine Market Size Estimation and Forecast by End-users
10.9 Germany Precision Medicine Market Analysis
10.10 UK Precision Medicine Market Analysis
10.11 France Precision Medicine Market Analysis
10.12 Italy Precision Medicine Market Analysis
10.13 Spain Precision Medicine Market Analysis
10.14 Russia Precision Medicine Market Analysis
10.15 Netherlands Precision Medicine Market Analysis
10.16 Denmark Precision Medicine Market Analysis
10.17 Rest of Europe Precision Medicine Market Analysis

11 Asia Pacific Precision Medicine Market Analysis
11.1 Key Findings
11.2 Asia Pacific Precision Medicine Market Attractiveness Index
11.3 Asia Pacific Precision Medicine Market by Country, 2025, 2030 & 2035 (US$ Billion)
11.4 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Country
11.5 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Product Type
11.5.1 Asia Pacific Therapeutics Market Size Estimation and Forecast by Type
11.5.2 Asia Pacific Diagnostics Market Size Estimation and Forecast by Type
11.6 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Application
11.7 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Technology
11.8 Asia Pacific Precision Medicine Market Size Estimation and Forecast by End-users
11.9 Japan Precision Medicine Market Analysis
11.10 China Precision Medicine Market Analysis
11.11 India Precision Medicine Market Analysis
11.12 Australia Precision Medicine Market Analysis
11.13 South Korea Precision Medicine Market Analysis
11.14 Singapore Precision Medicine Market Analysis
11.15 Thailand Precision Medicine Market Analysis
11.16 Rest of Asia Pacific Precision Medicine Market Analysis

12 Latin America Precision Medicine Market Analysis
12.1 Key Findings
12.2 Latin America Precision Medicine Market Attractiveness Index
12.3 Latin America Precision Medicine Market Size by Country, 2025, 2030 & 2035 (US$ Billion)
12.4 Latin America Precision Medicine Market Size Estimation and Forecast by Country
12.5 Latin America Precision Medicine Market Size Estimation and Forecast by Product Type
12.5.1 Latin America Therapeutics Market Size Estimation and Forecast by Type
12.5.2 Latin America Diagnostics Market Size Estimation and Forecast by Type
12.6 Latin America Precision Medicine Market Size Estimation and Forecast by Application
12.7 Latin America Precision Medicine Market Size Estimation and Forecast by Technology
12.8 Latin America Precision Medicine Market Size Estimation and Forecast by End-users
12.9 Brazil Precision Medicine Market Analysis
12.10 Mexico Precision Medicine Market Analysis
12.11 Argentina Precision Medicine Market Analysis
12.12 Colombia Precision Medicine Market Analysis
12.13 Rest of Latin America Precision Medicine Market Analysis

13 MEA Precision Medicine Market Analysis
13.1 Key Findings
13.2 MEA Precision Medicine Market Attractiveness Index
13.3 MEA Precision Medicine Market Size by Country, 2025, 2030 & 2035 (US$ Billion)
13.4 MEA Precision Medicine Market Size Estimation and Forecast by Country
13.5 MEA Precision Medicine Market Size Estimation and Forecast by Product Type
13.5.1 MEA Therapeutics Market Size Estimation and Forecast by Type
13.5.2 MEA Diagnostics Market Size Estimation and Forecast by Type
13.6 MEA Precision Medicine Market Size Estimation and Forecast by Application
13.7 MEA Precision Medicine Market Size Estimation and Forecast by Technology
13.8 MEA Precision Medicine Market Size Estimation and Forecast by End-users
13.9 GCC Precision Medicine Market Analysis
13.10 South Africa Precision Medicine Market Analysis
13.11 Egypt Precision Medicine Market Analysis
13.12 Rest of MEA Precision Medicine Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2024
14.2 Pfizer Inc.
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2020-2024
14.2.3.2 R&D, 2020-2024
14.2.3.3 Regional Market Shares, 2024
14.2.3.4 Business Market Shares, 2024
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.2.6 SWOT Analysis
14.3 Qiagen
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2020-2024
14.3.3.2 R&D, 2020-2024
14.3.3.3 Regional Market Shares, 2024
14.3.3.4 Business Market Shares, 2024
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Quest Diagnostics Incorporated
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2020-2024
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Agilent Technologies Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2020-2024
14.5.3.2 R&D, 2020-2024
14.5.3.3 Regional Market Shares, 2024
14.5.3.4 Business Market Shares, 2024
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Illumina, Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2020-2024
14.6.3.2 R&D, 2020-2024
14.6.3.3 Regional Market Shares, 2024
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Novartis AG
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2020-2024
14.7.3.2 R&D, 2020-2024
14.7.3.3 Regional Market Shares, 2024
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.7.6 SWOT Analysis
14.8 bioMerieux SA
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2020-2024
14.8.3.2 R&D, 2020-2024
14.8.3.3 Regional Market Shares, 2024
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 F. Hoffmann-La Roche Ltd
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2020-2024
14.9.3.2 R&D, 2020-2024
14.9.3.3 Regional Market Shares, 2024
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.9.6 SWOT Analysis
14.10 Abbott
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2020-2024
14.10.3.2 R&D, 2020-2024
14.10.3.3 Regional Market Shares, 2024
14.10.3.4 Business Market Shares, 2024
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Eli Lilly and Company
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2020-2024
14.11.3.2 R&D, 2020-2024
14.11.3.3 Regional Market Shares, 2024
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Thermo Fisher Scientific Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2020-2024
14.12.3.2 R&D, 2020-2024
14.12.3.3 Regional Market Shares, 2024
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 AstraZeneca
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2020-2024
14.13.3.2 R&D, 2020-2024
14.13.3.3 Regional Market Shares, 2024
14.13.3.4 Business Market Shares, 2024
14.13.4 Product Benchmarking
14.13.5 Strategic Outlook
14.14 Myriad Genetics Inc
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2020-2024
14.14.3.2 R&D, 2020-2024
14.14.3.3 Regional Market Shares, 2024
14.14.3.4 Business Market Shares, 2024
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
14.15 GSK plc
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2020-2024
14.15.3.2 R&D, 2020-2024
14.15.3.3 Regional Market Shares, 2024
14.15.3.4 Business Market Shares, 2024
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook
14.15.6 SWOT Analysis
14.16 Bristol-Myers Squibb Company
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Net Revenue, 2020-2024
14.16.3.2 R&D, 2020-2024
14.16.3.3 Regional Market Shares, 2024
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook
14.17 Danaher
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.3.1 Net Revenue, 2020-2024
14.17.3.2 R&D, 2020-2024
14.17.3.3 Regional Market Shares, 2024
14.17.3.4 Business Market Shares, 2024
14.17.4 Product Benchmarking
14.17.5 Strategic Outlook
14.18 Laboratory Corporation of America Holdings
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.3.1 Net Revenue, 2020-2024
14.18.3.2 Regional Market Shares, 2024
14.18.4 Product Benchmarking
14.18.5 Strategic Outlook
14.19 GE HealthCare
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Financial Analysis
14.19.3.1 Net Revenue, 2020-2024
14.19.3.2 R&D, 2020-2024
14.19.3.3 Regional Market Shares, 2024
14.19.4 Product Benchmarking
14.19.5 Strategic Outlook
14.20 Teva Pharmaceutical Industries Ltd.
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Financial Analysis
14.20.3.1 Net Revenue, 2020-2024
14.20.3.2 R&D, 2020-2024
14.20.3.3 Regional Market Shares, 2024
14.20.3.4 Business Market Shares, 2024
14.20.4 Product Benchmarking
14.20.5 Strategic Outlook
14.21 Bayer AG
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Financial Analysis
14.21.3.1 Net Revenue, 2020-2024
14.21.3.2 R&D, 2020-2024
14.21.3.3 Regional Market Shares, 2024
14.21.3.4 Business Market Shares, 2024
14.21.4 Product Benchmarking
14.21.5 Strategic Outlook
14.22 Biogen
14.22.1 Company Snapshot
14.22.2 Company Overview
14.22.3 Financial Analysis
14.22.3.1 Net Revenue, 2020-2024
14.22.3.2 R&D, 2020-2024
14.22.3.3 Business Market Shares, 2024
14.22.4 Product Benchmarking
14.22.5 Strategic Outlook
14.23 Johnson & Johnson
14.23.1 Company Snapshot
14.23.2 Company Overview
14.23.3 Financial Analysis
14.23.3.1 Net Revenue, 2020-2024
14.23.3.2 R&D, 2020-2024
14.23.3.3 Regional Market Shares, 2024
14.23.3.4 Business Market Shares, 2024
14.23.4 Product Benchmarking
14.23.5 Strategic Outlook
14.23.6 SWOT Analysis
14.24 Abnova Corporation
14.24.1 Company Snapshot
14.24.2 Company Overview
14.24.3 Product Benchmarking
14.24.4 Strategic Outlook
14.25 Bruker Corporation
14.25.1 Company Snapshot
14.25.2 Company Overview
14.25.3 Financial Analysis
14.25.3.1 Net Revenue, 2020-2024
14.25.3.2 R&D, 2020-2024
14.25.3.3 Regional Market Shares, 2024
14.25.3.4 Business Market Shares, 2024
14.25.4 Product Benchmarking
14.25.5 Strategic Outlook
14.26 23andMe, Inc.
14.26.1 Company Snapshot
14.26.2 Company Overview
14.26.3 Financial Analysis
14.26.3.1 Net Revenue, 2020-2024
14.26.3.2 R&D, 2020-2024
14.26.3.3 Regional Market Shares, 2024
14.26.3.4 Business Market Shares, 2024
14.26.4 Product Benchmarking
14.26.5 Strategic Outlook
14.27 Tempus
14.27.1 Company Snapshot
14.27.2 Company Overview
14.27.3 Product Benchmarking
14.27.4 Strategic Outlook
14.28 GRAIL Inc.
14.28.1 Company Snapshot
14.28.2 Company Overview
14.28.3 Financial Analysis
14.28.3.1 Net Revenue, 2021-2024
14.28.3.2 Regional Market Shares, 2024
14.28.3.3 Business Market Shares, 2024
14.28.4 Product Benchmarking
14.28.5 Strategic Outlook
14.29 Adaptive Biotechnologies
14.29.1 Company Snapshot
14.29.2 Company Overview
14.29.3 Financial Analysis
14.29.3.1 Net Revenue, 2020-2024
14.29.3.2 R&D, 2020-2024
14.29.3.3 Business Market Shares, 2024
14.29.4 Product Benchmarking
14.29.5 Strategic Outlook
14.30 Regeneron Pharmaceuticals
14.30.1 Company Snapshot
14.30.2 Company Overview
14.30.3 Financial Analysis
14.30.3.1 Net Revenue, 2020-2024
14.30.3.2 R&D, 2020-2024
14.30.3.3 Business Market Shares, 2024
14.30.4 Product Benchmarking
14.30.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1 Precision Medicine Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 2 Precision Medicine Market: International Trade Tariff Impact Recovery Scenarios Snapshot
Table 3 Precision Medicine Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: V- Shaped Recovery Scenario
Table 4 Precision Medicine Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: U- Shaped Recovery Scenario
Table 5 Precision Medicine Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: L- Shaped Recovery Scenario
Table 6 Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 7 Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 8 Therapeutics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 9 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 10 Inhibitor Drugs Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 11 Cell & Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 12 RNA-Based Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 13 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 14 Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 15 Diagnostic Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 16 Genetic Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Biomarker-based Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 18 Other Diagnostic Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 19 Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 20 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 21 Immunology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 22 CNS Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 23 Respiratory Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 25 Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 26 Gene Sequencing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 27 Drug Discovery Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 28 Big Data Analytics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 29 Companion Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 30 Bioinformatics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 31 Other Technologies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 32 Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 33 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 34 Diagnostic Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 35 Research & Academic Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 36 Other End-users Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 Precision Medicine Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 38 North America Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 39 North America Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 North America Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 North America Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 42 North America Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 43 North America Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 44 North America Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 45 U.S. Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 46 Canada Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 47 Europe Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 48 Europe Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 49 Europe Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 50 Europe Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 51 Europe Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 52 Europe Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 53 Europe Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 54 Germany Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 55 UK Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 56 France Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 57 Italy Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 58 Spain Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 59 Russia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 60 Netherlands Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 61 Denmark Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Rest of Europe Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 63 Asia Pacific Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 64 Asia Pacific Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 65 Asia Pacific Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 66 Asia Pacific Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 67 Asia Pacific Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 68 Asia Pacific Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 69 Asia Pacific Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 70 Japan Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 71 China Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 72 India Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 73 Australia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 74 South Korea Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 75 Singapore Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 76 Thailand Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 77 Rest of Asia Pacific Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 78 Latin America Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 79 Latin America Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 80 Latin America Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 81 Latin America Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 82 Latin America Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 83 Latin America Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 84 Latin America Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 85 Brazil Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 86 Mexico Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 87 Argentina Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 88 Colombia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 89 Rest of Latin America Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 90 MEA Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 91 MEA Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 92 MEA Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 93 MEA Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 94 MEA Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 95 MEA Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 96 MEA Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 97 GCC Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 98 South Africa Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 99 Egypt Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 100 Rest of MEA Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 101 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Pfizer Inc.: Product Benchmarking
Table 103 Pfizer Inc: Strategic Outlook
Table 104 Qiagen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Qiagen: Product Benchmarking
Table 106 Qiagen: Strategic Outlook
Table 107 Quest Diagnostics Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Quest Diagnostics Incorporated: Product Benchmarking
Table 109 Quest: Strategic Outlook
Table 110 Agilent Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Agilent Technologies Inc.: Product Benchmarking
Table 112 Agilent Technologies: Strategic Outlook
Table 113 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Illumina, Inc.: Product Benchmarking
Table 115 Illumina: Strategic Outlook
Table 116 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Novartis AG: Product Benchmarking
Table 118 Novartis: Strategic Outlook
Table 119 bioMerieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 bioMerieux SA: Product Benchmarking
Table 121 bioMerieux SA: Strategic Outlook
Table 122 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 124 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 125 Abbott : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Abbott: Product Benchmarking
Table 127 Abbott: Strategic Outlook
Table 128 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Eli Lilly and Company: Product Benchmarking
Table 130 Eli Lilly and Company: Strategic Outlook
Table 131 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 133 Thermo Fisher Scientific: Strategic Outlook
Table 134 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 AstraZeneca: Product Benchmarking
Table 136 AstraZeneca: Strategic Outlook
Table 137 Myriad Genetics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 Myriad Genetics Inc.: Product Benchmarking
Table 139 Biogen: Strategic Outlook
Table 140 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 141 GSK plc: Product Benchmarking
Table 142 GSK: Strategic Outlook
Table 143 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 144 Bristol-Myers Squibb Company: Product Benchmarking
Table 145 Bristol-Myers Squibb Company: Strategic Outlook
Table 146 Danaher : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 147 Danaher: Product Benchmarking
Table 148 Danaher: Strategic Outlook
Table 149 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 150 Laboratory Corporation of America Holdings: Product Benchmarking
Table 151 Laboratory Corporation of America Holdings: Strategic Outlook
Table 152 GE HealthCare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 153 GE HealthCare: Product Benchmarking
Table 154 GE Healthcare: Strategic Outlook
Table 155 Teva Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
Table 157 Teva: Strategic Outlook
Table 158 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 159 Bayer AG: Product Benchmarking
Table 160 Bayer AG: Strategic Outlook
Table 161 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 162 Biogen: Product Benchmarking
Table 163 Biogen: Strategic Outlook
Table 164 Johnson & Johnson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 165 Johnson & Johnson: Product Benchmarking
Table 166 J&J: Strategic Outlook
Table 167 Abnova Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 168 Abnova Corporation: Product Benchmarking
Table 169 Abnova Corporation: Strategic Outlook
Table 170 Bruker Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 171 Bruker Corporation: Product Benchmarking
Table 172 Bruker Corporation: Strategic Outlook
Table 173 23andMe, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 174 23andMe, Inc.: Product Benchmarking
Table 175 23andMe, Inc.: Strategic Outlook
Table 176 Tempus: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 177 Tempus: Product Benchmarking
Table 178 Tempus: Strategic Outlook
Table 179 GRAIL Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 180 GRAIL Inc.: Product Benchmarking
Table 181 GRAIL Inc.: Strategic Outlook
Table 182 Adaptive Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 183 Adaptive Biotechnologies: Product Benchmarking
Table 184 Adaptive Biotechnologies: Strategic Outlook
Table 185 Regeneron Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 186 Regeneron Pharmaceuticals: Product Benchmarking
Table 187 Regeneron Pharmaceuticals: Strategic Outlook
 
List of Figures
Figure 1 Precision Medicine Market Segmentation
Figure 2 Precision Medicine Market Attractiveness Index by Region
Figure 3 Precision Medicine Market by Product Type: Market Attractiveness Index
Figure 4 Precision Medicine Market by Application: Market Attractiveness Index
Figure 5 Precision Medicine Market by Technology: Market Attractiveness Index
Figure 6 Precision Medicine Market by End-users: Market Attractiveness Index
Figure 7 Precision Medicine Market: Market Dynamics
Figure 1 Healthcare Cold Chain Logistics Market: Impact Analysis
Figure 8 Precision Medicine Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 9 Precision Medicine Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 10 Precision Medicine Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 11 Short Term & Long Term Planning
Figure 12 Impact of U.S. and China Trade War
Figure 13 Most Impacted Countries
Figure 14 Global Market Tariff Sensitivity and Margin Pressure Analysis
Figure 15 Precision Medicine Market: Porter’s Five Forces Analysis
Figure 16 Global Precision Medicine Market: SWOT Analysis
Figure 17 Precision Medicine Market: PEST Analysis
Figure 18 Precision Medicine Market Attractiveness Index by Product Type
Figure 19 Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
Figure 20 Precision Medicine Market Share Forecast by Product Type, 2025, 2030, 2035 (%)
Figure 21 Therapeutics Market Attractiveness Index by Type
Figure 22 Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 23 Therapeutics Market Share Forecast by Type, 2025, 2030, 2035 (%)
Figure 24 Therapeutics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 25 Therapeutics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 26 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 27 Monoclonal Antibodies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 28 Inhibitor Drugs Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 29 Inhibitor Drugs Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 30 Cell & Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 31 Cell & Gene Therapies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 32 RNA-Based Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 33 RNA-Based Therapies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 34 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 35 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 36 Diagnostics Market Attractiveness Index by Type
Figure 37 Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 38 Diagnostics Market Share Forecast by Type, 2025, 2030, 2035 (%)
Figure 39 Diagnostic Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 40 Diagnostic Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 41 Genetic Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 42 Genetic Tests Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 43 Biomarker-based Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 Biomarker-based Tests Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 45 Other Diagnostic Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 46 Other Diagnostic Tests Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 47 Precision Medicine Market Attractiveness Index by Application
Figure 48 Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 49 Precision Medicine Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 50 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 51 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 52 Immunology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 53 Immunology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 54 CNS Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 55 CNS Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 56 Respiratory Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 57 Respiratory Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 58 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 59 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 60 Precision Medicine Market Attractiveness Index by Technology
Figure 61 Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
Figure 62 Precision Medicine Market Share Forecast by Technology, 2025, 2030, 2035 (%)
Figure 63 Gene Sequencing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 64 Gene Sequencing Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 65 Drug Discovery Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 66 Drug Discovery Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 67 Big Data Analytics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 68 Big Data Analytics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 69 Companion Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 70 Companion Diagnostics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 71 Bioinformatics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 72 Bioinformatics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 73 Other Technologies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 74 Other Technologies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 75 Precision Medicine Market Attractiveness Index by End-users
Figure 76 Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 77 Precision Medicine Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 78 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 79 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 80 Diagnostic Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 81 Diagnostic Centres Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 82 Research & Academic Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 83 Research & Academic Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 84 Other End-users Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 85 Other End-users Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 86 Precision Medicine Market Forecast by Region 2025 and 2035 (Revenue, CAGR%)
Figure 87 Precision Medicine Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 88 Precision Medicine Market by Region, 2025-2035 (US$ Bn)
Figure 89 North America Precision Medicine Market Attractiveness Index
Figure 90 North America Precision Medicine Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 91 North America Precision Medicine Market Forecast by Country, 2025-2035 (US$ billion)
Figure 92 North America Precision Medicine Market Share Forecast by Country, 2025 & 2035 (%)
Figure 93 North America Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
Figure 94 North America Precision Medicine Market Share Forecast by Product Type, 2025 & 2035 (%)
Figure 95 North America Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 96 North America Therapeutics Market Share Forecast by Type, 2025 & 2035 (%)
Figure 97 North America Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 98 North America Diagnostics Market Share Forecast by Type, 2025 & 2035 (%)
Figure 99 North America Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 100 North America Precision Medicine Market Share Forecast by Application, 2025 & 2035 (%)
Figure 101 North America Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
Figure 102 North America Precision Medicine Market Share Forecast by Technology, 2025 & 2035 (%)
Figure 103 North America Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 104 North America Precision Medicine Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 105 U.S. Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 106 Canada Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 107 Europe Precision Medicine Market Attractiveness Index
Figure 108 Europe Precision Medicine Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 109 Europe Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 110 Europe Precision Medicine Market Share Forecast by Country, 2025 & 2035 (%)
Figure 111 Europe Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
Figure 112 Europe Precision Medicine Market Share Forecast by Product Type, 2025 & 2035 (%)
Figure 113 Europe Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 114 Europe Therapeutics Market Share Forecast by Type, 2025 & 2035 (%)
Figure 115 Europe Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 116 Europe Diagnostics Market Share Forecast by Type, 2025 & 2035 (%)
Figure 117 Europe Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 118 Europe Precision Medicine Market Share Forecast by Application, 2025 & 2035 (%)
Figure 119 Europe Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
Figure 120 Europe Precision Medicine Market Share Forecast by Technology, 2025 & 2035 (%)
Figure 121 Europe Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 122 Europe Precision Medicine Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 123 Germany Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 124 UK Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 125 France Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 126 Italy Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 127 Spain Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 128 Russia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 129 Netherlands Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 130 Denmark Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 131 Rest of Europe Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 132 Asia Pacific Precision Medicine Market Attractiveness Index
Figure 133 Asia Pacific Precision Medicine Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 134 Europe Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 135 Europe Precision Medicine Market Share Forecast by Country, 2025 & 2035 (%)
Figure 136 Asia Pacific Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
Figure 137 Asia Pacific Precision Medicine Market Share Forecast by Product Type, 2025 & 2035 (%)
Figure 138 Asia Pacific Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 139 Asia Pacific Therapeutics Market Share Forecast by Type, 2025 & 2035 (%)
Figure 140 Asia Pacific Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 141 Asia Pacific Diagnostics Market Share Forecast by Type, 2025 & 2035 (%)
Figure 142 Asia Pacific Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 143 Asia Pacific Precision Medicine Market Share Forecast by Application, 2025 & 2035 (%)
Figure 144 Asia Pacific Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
Figure 145 Asia Pacific Precision Medicine Market Share Forecast by Technology, 2025 & 2035 (%)
Figure 146 Asia Pacific Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 147 Asia Pacific Precision Medicine Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 148 Japan Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 149 China Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 150 India Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 151 Australia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 152 South Korea Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 153 Singapore Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 154 Thailand Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 155 Rest of Asia Pacific Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 156 Latin America Precision Medicine Market Attractiveness Index
Figure 157 Latin America Precision Medicine Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 158 Latin America Precision Medicine Market Forecast by Country, 2025-2035 (US$ billion)
Figure 159 Latin America Precision Medicine Market Share Forecast by Country, 2025 & 2035 (%)
Figure 160 Latin America Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
Figure 161 Latin America Precision Medicine Market Share Forecast by Product Type, 2025 & 2035 (%)
Figure 162 Latin America Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 163 Latin America Therapeutics Market Share Forecast by Type, 2025 & 2035 (%)
Figure 164 Latin America Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 165 Latin America Diagnostics Market Share Forecast by Type, 2025 & 2035 (%)
Figure 166 Latin America Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 167 Latin America Precision Medicine Market Share Forecast by Application, 2025 & 2035 (%)
Figure 168 Latin America Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
Figure 169 Latin America Precision Medicine Market Share Forecast by Technology, 2025 & 2035 (%)
Figure 170 Latin America Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 171 Latin America Precision Medicine Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 172 Brazil Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 173 Mexico Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 174 Argentina Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 175 Colombia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 176 Rest of Latin America Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 177 MEA Precision Medicine Market Attractiveness Index
Figure 178 MEA Precision Medicine Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 179 MEA Precision Medicine Market Forecast by Country, 2025-2035 (US$ billion)
Figure 180 MEA Precision Medicine Market Share Forecast by Country, 2025 & 2035 (%)
Figure 181 MEA Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
Figure 182 MEA Precision Medicine Market Share Forecast by Product Type, 2025 & 2035 (%)
Figure 183 MEA Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 184 MEA Therapeutics Market Share Forecast by Type, 2025 & 2035 (%)
Figure 185 MEA Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 186 MEA Diagnostics Market Share Forecast by Type, 2025 & 2035 (%)
Figure 187 MEA Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 188 MEA Precision Medicine Market Share Forecast by Application, 2025 & 2035 (%)
Figure 189 MEA Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
Figure 190 MEA Precision Medicine Market Share Forecast by Technology, 2025 & 2035 (%)
Figure 191 MEA Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 192 MEA Precision Medicine Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 193 GCC Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 194 South Africa Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 195 Egypt Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 196 Rest of MEA Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 197 Precision Medicine Market: Company Share, 2024
Figure 198 Pfizer Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 199 Pfizer Inc.: R&D, 2020-2024 (US$ Million, AGR%)
Figure 200 Pfizer Inc.: Regional Market Shares, 2024
Figure 201 Pfizer Inc.: Business Market Shares, 2024
Figure 202 Pfizer Inc.: SWOT Analysis
Figure 203 Qiagen: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 204 Qiagen: R&D, 2020-2024 (US$ Million, AGR %)
Figure 205 Qiagen: Regional Market Shares, 2024
Figure 206 Qiagen: Business Market Shares, 2024
Figure 207 Quest Diagnostics Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 208 Agilent Technologies Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 209 Agilent Technologies Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 210 Agilent Technologies Inc.: Regional Market Shares, 2024
Figure 211 Agilent Technologies Inc.: Business Market Shares, 2024
Figure 212 Illumina, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR (%)
Figure 213 Illumina, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 214 Illumina, Inc.: Regional Market Shares, 2024
Figure 215 Novartis AG: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 216 Novartis AG: R&D, 2020-2024 (US$ Million, AGR %)
Figure 217 Novartis AG: Regional Market Shares, 2024
Figure 218 Novartis AG: SWOT Analysis
Figure 219 bioMerieux SA: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 220 bioMerieux SA: R&D, 2020-2024 (US$ Million, AGR %)
Figure 221 bioMerieux SA: Regional Market Shares, 2024
Figure 222 F. Hoffmann-La Roche Ltd: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 223 F. Hoffmann-La Roche Ltd: R&D, 2020-2024 (US$ Million, AGR (%))
Figure 224 F. Hoffmann-La Roche Ltd: Regional Market Shares, 2024
Figure 225 F. Hoffmann-La Roche Ltd: SWOT Analysis
Figure 226 Abbott: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 227 Abbott: R&D, 2020-2024 (US$ Million, AGR %)
Figure 228 Abbott: Regional Market Shares, 2024
Figure 229 Abbott: Business Market Shares, 2024
Figure 230 Eli Lilly and Company.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 231 Eli Lilly and Company.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 232 Eli Lilly and Company.: Regional Market Shares, 2024
Figure 233 Thermo Fisher Scientific Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 234 Thermo Fisher Scientific Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 235 Thermo Fisher Scientific Inc.: Regional Market Shares, 2024
Figure 236 AstraZeneca: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 237 AstraZeneca: R&D, 2020-2024 (US$ Million, AGR %)
Figure 238 AstraZeneca.: Regional Market Shares, 2024
Figure 239 AstraZeneca.: Business Market Shares, 2024
Figure 240 Myriad Genetics Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 241 Myriad Genetics Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 242 Myriad Genetics Inc.: Regional Market Shares, 2024
Figure 243 Myriad Genetics Inc.: Business Market Shares, 2024
Figure 244 GSK plc: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 245 GSK plc: R&D, 2020-2024 (US$ Million, AGR %)
Figure 246 GSK plc: Regional Market Shares, 2024
Figure 247 GSK plc: Business Market Shares, 2024
Figure 248 GSK plc: SWOT Analysis
Figure 249 Bristol-Myers Squibb Company: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 250 Bristol-Myers Squibb Company: R&D, 2020-2024 (US$ Million, AGR %)
Figure 251 Bristol-Myers Squibb Company: Regional Market Shares, 2024
Figure 252 Danaher: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 253 Danaher: R&D, 2020-2024 (US$ Million, AGR %)
Figure 254 Danaher: Regional Market Shares, 2024
Figure 255 Danaher: Business Market Shares, 2024
Figure 256 Laboratory Corporation of America Holdings: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 257 Laboratory Corporation of America Holdings: Regional Market Shares, 2024
Figure 258 GE HealthCare: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 259 GE HealthCare: R&D, 2020-2024 (US$ Million, AGR %)
Figure 260 GE HealthCare: Regional Market Shares, 2024
Figure 261 Teva Pharmaceutical Industries Ltd: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 262 Teva Pharmaceutical Industries Ltd: R&D, 2020-2024 (US$ Million, AGR %)
Figure 263 Teva Pharmaceutical Industries Ltd: Regional Market Shares, 2024
Figure 264 Teva Pharmaceutical Industries Ltd: Business Market Shares, 2024
Figure 265 Bayer AG: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 266 Bayer AG: R&D, 2020-2024 (US$ Million, AGR %)
Figure 267 Bayer AG: Regional Market Shares, 2024
Figure 268 Bayer AG: Business Market Shares, 2024
Figure 269 Biogen: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 270 Biogen: R&D, 2020-2024 (US$ Million, AGR %)
Figure 271 Biogen: Business Market Shares, 2024
Figure 272 Johnson & Johnson: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 273 Johnson & Johnson: R&D, 2020-2024 (US$ Million, AGR %)
Figure 274 Johnson & Johnson: Regional Market Shares, 2024
Figure 275 Johnson & Johnson: Business Market Shares, 2024
Figure 276 Johnson & Johnson: SWOT Analysis
Figure 277 Bruker Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 278 Bruker Corporation: R&D, 2020-2024 (US$ Million, AGR %)
Figure 279 Bruker Corporation: Regional Market Shares, 2024
Figure 280 Bruker Corporation: Business Market Shares, 2024
Figure 281 23andMe, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 282 23andMe, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 283 23andMe, Inc.: Regional Market Shares, 2024
Figure 284 23andMe, Inc.: Business Market Shares, 2024
Figure 285 GRAIL Inc.: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 286 GRAIL Inc.: Regional Market Shares, 2024
Figure 287 GRAIL Inc.: Business Market Shares, 2024
Figure 288 Adaptive Biotechnologies: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 289 Adaptive Biotechnologies: R&D, 2020-2024 (US$ Million, AGR %)
Figure 290 Adaptive Biotechnologies: Business Market Shares, 2024
Figure 291 Regeneron Pharmaceuticals: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 292 Regeneron Pharmaceuticals: R&D, 2020-2024 (US$ Million, AGR %)
Figure 293 Regeneron Pharmaceuticals: Business Market Shares, 2024